β− Arrestins: structure, function, physiology, and pharmacological perspectives

J Wess, AB Oteng, O Rivera-Gonzalez… - Pharmacological …, 2023 - Elsevier
The two β-arrestins, β-arrestin-1 and-2 (systematic names: arrestin-2 and-3, respectively),
are multifunctional intracellular proteins that regulate the activity of a very large number of …

Current insights and progress in the clinical management of head and neck cancer

MN Amaral, P Faísca, HA Ferreira, MM Gaspar… - Cancers, 2022 - mdpi.com
Simple Summary Head and neck cancer (HNC) incidence has been steadily increasing
since the 1990s. While the multimodal treatment approach for localized HNC is well …

A review of advanced cutaneous melanoma therapies and their mechanisms, from immunotherapies to lysine histone methyl transferase inhibitors

RS de Oliveira Filho, DA de Oliveira, MM Nisimoto… - Cancers, 2023 - mdpi.com
Simple Summary Advanced cutaneous melanoma is the most aggressive type of skin cancer
and has variable rates of treatment response. Currently, there are some classes of …

Exosome-based immunotherapy as an innovative therapeutic approach in melanoma

S Babaei, M Fadaee, H Abbasi-Kenarsari… - Cell Communication and …, 2024 - Springer
The malignant form of melanoma is one of the deadliest human cancers that accounts for
almost all of the skin tumor-related fatalities in its later stages. Achieving an exhaustive …

Current treatment of melanoma brain metastases

A Nowacka, A Fajkiel-Madajczyk, J Ohla… - Cancers, 2023 - mdpi.com
Simple Summary Melanoma has the highest mortality rate of all skin cancers and its
prognosis is worsened by metastasis to the brain. Before discovering new treatments for …

BRAF V600-mutated metastatic melanoma and targeted therapy resistance: an update of the current knowledge

L Florent, C Saby, F Slimano, H Morjani - Cancers, 2023 - mdpi.com
Simple Summary Metastatic melanoma is the most lethal skin cancer due to its high
metastatic potential and resistance to treatment. The advent of targeted therapies has …

Autophagy as a targeted therapeutic approach for skin cancer: Evaluating natural and synthetic molecular interventions

ML Ali, AH Roky, SMAK Azad, AH Shaikat… - Cancer Pathogenesis …, 2024 - mednexus.org
Skin cancer, a prevalent malignancy worldwide, poses significant health concerns owing to
its increasing incidence. Autophagy, a natural cellular process, is a pivotal event in skin …

Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors in Advanced Melanoma Patients: A Systematic Review and Meta-Analysis

JN Priantti, M Vilbert, T Madeira, FCA Moraes… - Cancers, 2023 - mdpi.com
Simple Summary Approximately 50% of patients with melanoma harbor a BRAF mutation
and are eligible for targeted therapy with BRAF/MEK inhibitors (BRAFi/MEKi). Despite a …

Encapsulation of a small-molecule drug based on substituted 2-aminothiophenes in calcium carbonate carriers for therapy of melanoma

TE Karpov, A Rogova, DR Akhmetova… - Biomaterials …, 2024 - pubs.rsc.org
Although small molecule drugs are widely used in chemotherapy, their low bioavailability,
low-concentrated dose in the tumor zone, systemic toxicity, and chemoresistance can …

Determination of some isoquinoline alkaloids in extracts obtained from selected plants of the Ranunculaceae, Papaveraceae and Fumarioideae families by liquid …

J Misiurek, T Plech, B Kaproń, A Makuch-Kocka… - Molecules, 2023 - mdpi.com
Alkaloids are heterocyclic bases with widespread occurrence in nature. Plants are rich and
easily accessible sources of them. Most isoquinoline alkaloids have cytotoxic activity for …